555win cung cấp cho bạn một cách thuận tiện, an toàn và đáng tin cậy [xổ số thứ bảy tuần rồi]
LIAISON ® MeMed BV ® is an innovative immune-based protein signature test that measures and computationally integrates the levels of three host-proteins (TRAIL, IP-10 and CRP) to deliver fast, easy-to-interpret results indicating the likelihood of a bacterial or viral infection.
Feb 10, 2025 · MeMed BV™ is an FDA-approved test that measures the levels of three proteins (CRP, IP-10 and TRAIL), quantified by immunoassay and indexed to an algorithm to predict the likelihood of bacterial vs. viral infections.
Get answers to frequently asked questions about MeMed's diagnostic test as the MeMed BV® and the MeMed Key® platform. Find availability, and how our technology works to help you.
MeMed BV® is a regulatory-cleared host-immune response assay for accurately distinguishing between bacterial and viral infections within the ED workflow in just 15 minutes.
MeMed BV® analyzes host immune response to distinguish between bacterial and viral infections in 15 minutes—helping clinicians make fast, informed decisions.
LIAISON® MeMed BV® is a novel immune-based protein signature test that differentiates the etiology of acute infections – viral or bacterial and can identify a co-infection.
The technology, MeMed BV, works through MeMed key platform, decoding the host immune response to the infection to differentiate between viral and bacterial infection.
Sep 20, 2021 · MeMed BV ® is a first-of-its-kind immune-based protein signature test, developed and validated over the course of decade-long collaborations with leading academic and commercial partners.
MeMed BV® is the first FDA-cleared host-immune response assay for accurately distinguishing between bacterial and viral infections in just 15 minutes.
The LIAISON MeMed BV test is a new, FDA-approved assay that relies on markers of the host immune response to infection for B-V discrimination.
Bài viết được đề xuất: